Granuloma annulare clinical trials Five recognized forms or clinical variants of granuloma annulare have been identified. The most common form is localized granuloma annulare. , generalized or disseminated, linear, perforating, and subcutaneous) occur less often than the localized form.
Granuloma annulare is difficult to treat and there are a limited number of clinical trials to reliably inform patients and physicians of the treatment options. Patients with generalized granuloma annulare characteristically present with a few to thousands of 1- to 2- mm papules or nodules that range in color from flesh- toned to erythematous and involve multiple body regions. Granuloma annulare clinical trials. Aug 02, · If granuloma annulare ( GA) does not cause bothersome symptoms like itching, then it usually does not need to be treated.
Age ( years) Gender. The format for each of the following is: The name of the trial, followed by whether the trial is recruiting patients,. Clinical Trials data for Granuloma annulare is grouped into the following categories: - View by trial name; Clinical Trials by trial name. The four other forms ( i.
Oct 29, · Granuloma annulare ( GA) is a benign inflammatory dermatosis. Granuloma annulare is a benign, usually self- limiting, cutaneous dermatosis, which typically presents as asymptomatic, flesh- colored or red papules, frequently arranged in. Home About Us Contact Us Blogs Videos News Products FAQS.
[ 3] [ 7] If GA does cause symptoms, it can be difficult to find the best treatment, because treatment options for GA have not been studied in large clinical trials. Fortunately, most lesions of granuloma annulare disappear with no treatment within two years. XpertTrial uses a proprietary algorithm to help you find and enroll in clinical trials.